High-sensitivity cardiac troponin assays promise better diagnostic accuracy for acute myocardial infarction, allowing earlier and more effective treatment for patients. This is why it is essential that laboratory medicine professionals and clinicians understand the performance of these tests and how to use them. With this challenge in mind, an expert group of laboratorians, emergency medicine clinicians, and cardiologists worked for more than 2 years on hs-cTn education materials, following-up on a mini-review that tackled the question, how does an assay become designated high-sensitivity? This group, all members of the International Federation of Clinical Chemistry and Laboratory Medicine Task Force on Clinical Applications of Cardiac Bio-Markers, also collaborated with representatives from in vitro diagnostics companies who have expertise in hs-cTn troponin immunoassays.
Implementing High Sensitivity Cardiac Troponin Assays